首页> 外文期刊>Nature >BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks
【24h】

BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks

机译:BRCA1控制在Tus / Ter繁育的哺乳动物复制叉处的同源重组

获取原文
获取原文并翻译 | 示例
       

摘要

Replication fork stalling can promote genomic instability, predisposing to cancer and other diseases. Stalled replication forks may be processed by sister chromatid recombination (SCR), generating error-free or error-prone homologous recombination (HR) outcomes. In mammalian cells, a long-standing hypothesis proposes that the major hereditary breast/ovarian cancer predisposition gene products, BRCA1 and BRCA2, control HR/SCR at stalled replication forks. Although BRCA1 and BRCA2 affect replication fork processing, direct evidence that BRCA gene products regulate homologous recombination at stalled chromosomal replication forks is lacking, due to a dearth of tools for studying this process. Here we report that the Escherichia coli Tus/Ter complex can be engineered to induce site-specific replication fork stalling and chromosomal HR/SCR in mouse cells. Tus/Ter-induced homologous recombination entails processing of bidirectionally arrested forks. We find that the Brcal car-boxy (C)-terminal tandem BRCT repeat and regions of Brcal encoded by exon 11 -two Brcal elements implicated in tumour suppression-control Tus/Ter-induced homologous recombination. Inactivation of either Brcal or Brca2 increases the absolute frequency of 'long-tract' gene conversions at Tus/Ter-stalled forks, an outcome not observed in response to a site-specific endonuclease-mediated chromosomal double-strand break. Therefore, homologous recombination at stalled forks is regulated differently from homologous recombination at double-strand breaks arising independently of a replication fork. We propose that aberrant long-tract homologous recombination at stalled replication forks contributes to genomic instability and breast/ovarian cancer predisposition in BRCA mutant cells.%一个复制叉的停滞能启动导致癌症的病理性事件。虽然已有人提出肿瘤抑制因子BRCA1和BRCA2也许会在停滞的复制叉上调控同源重组(HR),但此前却一直没有可能在哺乳动物细胞中获得关于这一点的直接证据,原因是没有一个能够在其中验证这一点的实验系统。Ralph Scully及同事现在建立了一个系统,它允许对哺乳动物细胞中某一特定的停滞复制叉进行调控。细菌Tus/Ter复合物能够造成一个复制叉的双向停滞,这需要由BRCA1/BRCA2介导的HR才能使其恢复。然而,异常的长段HR被发现在没有BRCA蛋白时会出现在停滞的复制叉上,这为这些细胞易于发生癌变提供了一个基础。
机译:复制叉停转会促进基因组不稳定,易患癌症和其他疾病。停滞的复制叉可以通过姐妹染色单体重组(SCR)进行处理,从而产生无错或易错的同源重组(HR)结果。在哺乳动物细胞中,一个长期的假设提出,主要的遗传性乳腺癌/卵巢癌易感基因产物BRCA1和BRCA2在停滞的复制叉处控制HR / SCR。尽管BRCA1和BRCA2影响复制叉的加工,但是由于缺乏研究该过程的工具,因此缺乏直接证据证明BRCA基因产物在停滞的染色体复制叉处调节同源重组。在这里我们报告,大肠杆菌Tus / Ter复合体可以被工程化,以诱导小鼠细胞中的站点特定复制叉停滞和染色体HR / SCR。 Tus / Ter诱导的同源重组需要双向停叉的加工。我们发现,Brcal羧基(C)端串联BRCT重复和由外显子11编码的Brcal区域-牵连在肿瘤抑制控制Tus / Ter诱导的同源重组中的两个Brcal元素。 Brcal或Brca2的失活会增加在Tus / Ter停滞的叉子上“长途”基因转化的绝对频率,这是对位点特异性内切核酸酶介导的染色体双链断裂未观察到的结果。因此,失速叉的同源重组与独立于复制叉产生的双链断裂处的同源重组受到不同的调节。我们认为,停滞的复制叉处异常的长途同源重组可导致BRCA突变细胞的基因组不稳定和乳腺癌/卵巢癌的易感性。 BRCA1和BRCA2也许会在停滞的复制叉上重新合成(HR),但却却一直没有可能在微观细胞中获得关于这一点的直接证据,原因是没有一个能够在其中验证这一点的实验系统。RalphScully和同事现在建立了一个系统,它允许对哺乳动物细胞中某些特定的停滞复制叉进行替换。细菌Tus / Ter复合物能够造成一个复制叉的双向停滞,这需要由BRCA1 / BRCA2介导的HR能实现恢复。然而,异常的长段HR被发现在没有BRCA蛋白时会出现在停滞的复制叉上,这为这些细胞容易发生癌变提供了一个基础。

著录项

  • 来源
    《Nature》 |2014年第7506期|556-559A2|共5页
  • 作者单位

    Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA;

    Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA,Temple University, 1801 North Broad Street, Philadelphia, Pennsylvania 19122, USA;

    Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA,Brandeis University, 415 South Street, Waltham, Massachusetts 02453, USA;

    Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA,University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01655, USA;

    Princeton University, 101 Lewis Thomas Laboratory, Washington Road, Princeton, New Jersey 08544, USA;

    NIDDK, National Institutes of Health, Building 10, Room 9N105, 10 Center Drive, Bethesda, Maryland 20814, USA;

    Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:04

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号